Imagine a World​
Without Diabetes

Functional Core

Learn about our mission

Paulex Bio stands at the threshold of what could be a transformative breakthrough for Type 1 and Type 2 diabetes: beta cell regeneration through an oral medicine designed to eliminate the root cause of diabetes.

Learn about investing in our mission

We’re in the process of a Pre-IPO investment opportunity for accredited investors only through MDB Capital. Learn how to support our mission through investment.*

Pre-IPO

View our investor presentation

Get an overview of diabetes, Paulex Bio and how you can join us as we tackle this important opporunity together.

Join Our Mailing List

I Want To :

Check all that apply

  • Join the mailing list
  • Get the Investor Presentation
  • Attend a live online presentation with Paulex Bio management
  • Request a meeting with Paulex Bio management

* The securities will be offered to accredited investors only pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended (the "Securities Act"). This does not constitute an offer to sell nor a solicitation of an offer to purchase any securities in any jurisdiction in which such an offer or soli citation is not authorized and does not constitute an offer within any jurisdiction to any person to whom such offer would be unlawful. Further, the securities to be offered by Paulex have not bee n registered under the Securities Ac t, any state securities laws or the securities laws of any other jurisdiction and may not be offered or sold absent registration or an applicable exemption f rom the registration requirem ents.

MDB Capital is serving as the placement agent for the Paulex Bio private placement investment opportunity. Investing in early stage private companies is speculative and involves risks, including illiquidity and loss of principal. Pas

Securities trading, account management, and investment banking services are offered by MDB Capital, a registered broker -dealer and member of FINRA and SIPC. Please view the MDB Capital C ustomer Relationship Summary (Form CRS) and other important disclosure information at mdb.com/disclosures. For additional information, please visit www.mdb.com or contact us at 945.262.9010.